1
|
Akande RT, Fouche G, Famuyide IM, Makhubu FN, Nkadimeng SM, Aro AO, Kayoka-Kabongo PN, McGaw LJ. Anthelmintic and antimycobacterial activity of fractions and compounds isolated from Cissampelos mucronata. JOURNAL OF ETHNOPHARMACOLOGY 2022; 292:115130. [PMID: 35292375 DOI: 10.1016/j.jep.2022.115130] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 02/20/2022] [Accepted: 02/20/2022] [Indexed: 06/14/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Cissampelos mucronata A. Rich., a perennial climber belonging to the family Menispermaceae, has been used traditionally to treat parasites and tuberculosis-related symptoms. Co-infection of helminth parasites and tuberculosis-causing pathogens heightens the risk of developing active tuberculosis. AIM OF THE STUDY The aim was to isolate and characterize antimycobacterial compounds from Cissampelos mucronata and to investigate their antibiofilm and anthelmintic efficacy as well as cytotoxicity. MATERIALS AND METHODS The acetone extract of C. mucronata leaves and stems was fractionated by vacuum liquid chromatography using hexane, ethyl acetate, acetone and methanol:chloroform (3:7). Separation of the active ethyl acetate fraction by column and preparative thin layer chromatography led to the isolation and identification of five compounds using NMR and LC-MS, as well as GC-MS for non-polar compounds. The anthelmintic, antimycobacterial, antibiofilm, antioxidant and anti-inflammatory effects as well as cytotoxicity of the fractions and compounds were determined. RESULTS The ethyl acetate fraction had the best antimycobacterial activity (MIC = 0.015-0.08 mg/ml). The fractions were relatively non-toxic to Vero cells (0.03-0.79 mg/ml) and had good anti-inflammatory and antibiofilm effects. Five compounds were identified as stigmasterol, hentriacontane, simiarenol, nonacosene and carbonic acid. Nonacosene had moderate anthelmintic effects but poor antimycobacterial activity (MIC = 0.375 mg/ml). Nonacosene and hentriacontane had good biofilm inhibitory effect (90-100%). CONCLUSIONS This study reveals that C. mucronata is a potential source of promising compounds with a range of useful bioactivities that support its use in traditional medicine. Development of plant-based remedies may assist in reducing the impact of co-infections with helminth parasites and tuberculosis-causing mycobacteria.
Collapse
Affiliation(s)
- R T Akande
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa; Nuclear Technology Centre, Nigeria Atomic Energy Commission, Sheda, Abuja, Nigeria.
| | - G Fouche
- Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa.
| | - I M Famuyide
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa.
| | - F N Makhubu
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa.
| | - S M Nkadimeng
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa.
| | - A O Aro
- Department of Agriculture and Animal Health, College of Agriculture and Environmental Science, University of South Africa, Florida Campus, Private Bag X6, Florida, Roodepoort, 1710, South Africa.
| | - P N Kayoka-Kabongo
- Department of Agriculture and Animal Health, College of Agriculture and Environmental Science, University of South Africa, Florida Campus, Private Bag X6, Florida, Roodepoort, 1710, South Africa.
| | - L J McGaw
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, 0110, Pretoria, South Africa.
| |
Collapse
|
2
|
Nair JJ, van Staden J. Insights to the tribe Haemantheae of the South African Amaryllidaceae. JOURNAL OF ETHNOPHARMACOLOGY 2022; 292:115177. [PMID: 35263631 DOI: 10.1016/j.jep.2022.115177] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2021] [Revised: 02/18/2022] [Accepted: 03/03/2022] [Indexed: 06/14/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE The family Amaryllidaceae has been documented in traditional systems of medicine around the globe. Its member tribe Haemantheae occurs chiefly in South Africa, where around twenty of its species are identifiable with a wide variety of functions in such practices. AIM OF THE STUDY This account details work published from 2013 to 2020 on the tribe Haemantheae involving Clivia, Cryptostephanus, Haemanthus, Scadoxus and Gethyllis. Focus is maintained on the traditional medicinal aspects, pharmacological activities and identification of the active principles. Significant effort is also made to outline the molecular basis to some of these effects. MATERIALS AND METHODS The major search engine platforms including, SciFinder, Scopus, ScienceDirect, PubMed and Google Scholar were utilized at the literature consolidation stage. Keywords engaged in the process included 'Amaryllidaceae' and 'Haemantheae' as well as individual genera and specie names. RESULTS Twenty-four species of the five genera were encountered over the designated time frame. New traditional medicinal information has emerged on nine of these species, where usage ranged from the treatment of wounds and infections, circulatory and gastrointestinal issues to AIDS and TB. Significant amounts of new data also appeared in relation to the antimicrobial, anti-inflammatory, antioxidant, anticholinesterase, antidepressive and cytotoxic effects of these plants. Potent activities were observed in some instances, as they were in regards to the anti-inflammatory effects of some Gethyllis species in their cyclooxygenase-inhibitory effects. The entities behind these activities, with few exceptions, were shown to be isoquinoline alkaloids which are known to dominate the chemistry of the Amaryllidaceae. Interesting observations were also made for the mechanisms behind some of the effects, notably in the inflammatory and motorneuron disease arenas. CONCLUSIONS The tribe Haemantheae has proved to be a rich and diverse platform for studies of the Amaryllidaceae in the key areas of traditional medicine, pharmacology and phytochemistry. Indigenous knowledge has played a significant role in guiding the biological evaluations, while identification of the active principles has been bolstered by the exceedingly rich alkaloid diversity of the Amaryllidaceae. As such, Haemantheae should continue to feature prominently in drug discovery efforts targeted at the family.
Collapse
Affiliation(s)
- Jerald J Nair
- Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville, 3209, South Africa
| | - Johannes van Staden
- Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville, 3209, South Africa.
| |
Collapse
|
3
|
Traditional Medicinal Plants as a Source of Antituberculosis Drugs: A System Review. BIOMED RESEARCH INTERNATIONAL 2021; 2021:9910365. [PMID: 34541000 PMCID: PMC8448615 DOI: 10.1155/2021/9910365] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Accepted: 08/09/2021] [Indexed: 12/02/2022]
Abstract
Medicinal plants are the chief components in the different oriental formulations in different traditional medical systems worldwide. As a thriving source of medicine, the medicinal plants with antituberculosis (TB) properties inspire the pharmacists to develop new drugs based on their active components or semimetabolites. In the present review, the anti-TB medicinal plants were screened from the scientific literatures, based on the botanical classification and the anti-TB activity. The obtained anti-TB medicinal plants were categorized into three different categories, viz., 159 plants critically examined with a total 335 isolated compounds, 131 plants with their crude extracts showing anti-TB activity, and 27 plants in literature with the prescribed formula by the traditional healers. Our systemic analysis on the medicinal plants can assist the discovery of novel and more efficacious anti-TB drugs.
Collapse
|
4
|
Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones. Med Chem Res 2021; 30:1523-1533. [PMID: 34131377 PMCID: PMC8192043 DOI: 10.1007/s00044-021-02735-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 04/28/2021] [Indexed: 10/25/2022]
Abstract
8-Nitro-1,3-benzothiazin-4-ones (BTZs), with BTZ043 and PBTZ169 as the most advanced compounds, represent a new class of potent antitubercular agents, which irreversibly inhibit decaprenylphosphoryl-β-d-ribose-2'-epimerase (DprE1), an enzyme crucial for cell wall synthesis in the pathogen Mycobacterium tuberculosis. Synthesis, structural characterization and in vitro testing against Mycobacterium aurum DSM 43999 and M. tuberculosis H37Rv of halogenated 2-(4-ethoxycarbonylpiperazin-1-yl)-1,3-benzothiazin-4-ones lacking a nitro group are reported. X-ray crystallography reveals that the structure of the BTZ scaffold can significantly deviate from planarity. In contrast to recent reports, the results of the present study indicate that further investigation of halogenated non-nitro BTZs for antitubercular activity is less than a promising approach.
Collapse
|
5
|
Gado DA, Abdalla MA, Ahmed AS, Madikizela B, Nkadimeng SM, Ehlers MM, McGaw LJ. In vitro antibacterial activity of Loxostylis alata extracts and isolated compounds against Salmonella species. BMC Complement Med Ther 2021; 21:121. [PMID: 33849505 PMCID: PMC8042679 DOI: 10.1186/s12906-021-03292-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 03/29/2021] [Indexed: 01/21/2023] Open
Abstract
Background Owing to antibiotic resistance, alternative antimicrobials from medicinal plants are receiving attention as leads for anti-infective agents. This study aimed to investigate selected tree species and their constituents for activity against bacterial foodborne pathogens, particularly Salmonella serovars. Methods Antibacterial activity of ten plant species was determined by serial microdilution against bacteria implicated in causing gastrointestinal ailments. Active compounds were isolated from Loxostylis alata using bioassay-guided fractionation. Antioxidant activity was determined using free-radical scavenging assays. Cytotoxicity and genotoxicity of the extracts was ascertained on Vero cells, and using the Ames assay respectively. Results Extracts had low to moderate MIC values from 0.04 to 2.5 mg/mL. Protorhus longifolia and Loxostylis alata were most active and L. alata had the highest selectivity index value (2.51) against Salmonella Typhimurium, as well as high antioxidant activity. Cytotoxicity values ranged from 0.02 to 0.47 mg/mL, while tested extracts were not genotoxic. Bioactive compounds isolated from L. alata included delicaflavone and a polymethoxyflavone. Conclusions The Loxostylis alata leaf extract had strong activity against Salmonella serovars but isolated compounds were less active, indicating likely synergistic effects. Extracts of L. alata are promising candidates for development of antimicrobial preparations or food additives against microbial contamination.
Collapse
Affiliation(s)
- Dorcas A Gado
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa.,Regional Laboratory for Animal Influenzas and other Transboundary Animal Diseases, National Veterinary Research Institute, PMB 01, Vom, Plateau State, Nigeria
| | - Muna Ali Abdalla
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa. .,Department of Food Science and Technology, Faculty of Agriculture, University of Khartoum, 13314, Khartoum North, Sudan.
| | - Aroke S Ahmed
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa
| | - Balungile Madikizela
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa
| | - Sanah M Nkadimeng
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa
| | - Marthie M Ehlers
- Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, PO Box X323, Arcadia 0007, Pretoria, South Africa.,National Health Laboratory Service, Tshwane Academic Division, Pretoria, South Africa
| | - Lyndy J McGaw
- Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, Pretoria, South Africa
| |
Collapse
|
6
|
Dantas FGDS, Castilho PFD, Almeida-Apolonio AAD, Araújo RPD, Oliveira KMPD. Mutagenic potential of medicinal plants evaluated by the Ames Salmonella/microsome assay: A systematic review. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2020; 786:108338. [PMID: 33339578 DOI: 10.1016/j.mrrev.2020.108338] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 10/02/2020] [Accepted: 10/06/2020] [Indexed: 01/21/2023]
Abstract
The Ames test has become one of the most commonly used tests to assess the mutagenic potential of medicinal plants since they have several biological activities and thus have been used in traditional medicine and in the pharmaceutical industry as a source of raw materials. Accordingly, this review aims to report previous use of the Ames test to evaluate the mutagenic potential of medicinal plants. A database was constructed by curating literature identified by a search on the electronic databases Medline (via Pubmed), Science Direct, Scopus, and Web of Science from 1975 to April 2020, using the following terms: "genotoxicity tests" OR "mutagenicity tests" OR "Ames test" AND "medicinal plants." From the research, 239 articles were selected, including studies of 478 species distributed across 111 botanical families, with Fabaceae, Asteraceae and Lamiaceae being the most frequent. It was identified that 388 species were non-mutagenic. Of these, 21% (83/388) showed antimutagenic potential, most notable in the Lamiaceae family. The results also indicate that 18% (90/478) of the species were mutagenic, of which 54% were mutagenic in the presence and absence of S9. Strains TA98 and TA100 showed a sensitivity of 93% in detecting plant extracts with mutagenic potential. However, the reliability of many reviewed studies regarding the botanical extracts may be questioned due to technical issues, such as testing being performed only in the presence or absence of S9, use of maximum doses below 5 mg/plate and lack of information on the cytotoxicity of tested doses. These methodological aspects additionally demonstrated that a discussion about the doses used in research on mixtures, such as the ones assessed with botanical extracts and the most sensitive strains employed to detect the mutagenic potential, should be included in a possible update of the guidelines designed by the regulatory agencies.
Collapse
Affiliation(s)
- Fabiana Gomes da Silva Dantas
- Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil; Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
| | | | | | - Renata Pires de Araújo
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil; Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados, MS, Brazil
| | - Kelly Mari Pires de Oliveira
- Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil; Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.
| |
Collapse
|
7
|
Cock IE, Van Vuuren SF. The traditional use of southern African medicinal plants for the treatment of bacterial respiratory diseases: A review of the ethnobotany and scientific evaluations. JOURNAL OF ETHNOPHARMACOLOGY 2020; 263:113204. [PMID: 32730881 PMCID: PMC7383173 DOI: 10.1016/j.jep.2020.113204] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Revised: 07/07/2020] [Accepted: 07/20/2020] [Indexed: 05/04/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Multiple plant species were used traditionally in southern Africa to treat bacterial respiratory diseases. This review summarises this usage and highlights plant species that are yet to be verified for these activities. AIM OF THE STUDY This manuscript reviews the traditional usage of southern African plant species to treat bacterial respiratory diseases with the aim of highlighting gaps in the literature and focusing future studies. MATERIALS AND METHODS An extensive review of ethnobotanical books, reviews and primary scientific studies was undertaken to identify southern African plants which are used in traditional southern African medicine to treat bacterial respiratory diseases. We also searched for southern African plants whose inhibitory activity against bacterial respiratory pathogens has been conmfirmed, to highlight gaps in the literature and focus future studies. RESULTS One hundred and eighty-seven southern African plant species are recorded as traditional therapies for bacterial respiratory infections. Scientific evaluations of 178 plant species were recorded, although only 42 of these were selected for screening on the basis of their ethnobotanical uses. Therefore, the potential of 146 species used teraditionally to treat bacterial respiratory diseases are yet to be verified. CONCLUSIONS The inhibitory properties of southern African medicinal plants against bacterial respiratory pathogens is relatively poorly explored and the antibacterial activity of most plant species remains to be verified.
Collapse
Affiliation(s)
- Ian E Cock
- School of Environment and Science, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland, 4111, Australia; Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland, 4111, Australia.
| | - Sandy F Van Vuuren
- Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, 2193, South Africa
| |
Collapse
|